Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02330562 |
| Title | Study of Marizomib With Bevacizumab in Bevacizumab-Naïve Subjects With WHO Grade IV Malignant Glioma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Triphase Research and Development I Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Californai, Irvine | Orange | California | 92868 | United States | Details | |
| John Wayne Cancer Institute | Santa Monica | California | 90404 | United States | Details | |
| Weill Cornell Medical College | New York | New York | 10065 | United States | Details | |
| Duke Univ Medical Center | Durham | North Carolina | 27710 | United States | Details | |
| Princess Margaret Hospital, Medical Oncology | Toronto | Ontario | M5G 2M9 | Canada | Details |